Position in ELVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,786,019
+$12,903,569 QoQ
Shares Held
330,759
+67.7% QoQ
Ownership
0.451%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#49
of 208 holders
Holding Since
Sep 2024
4 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in ELVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LORD, ABBETT & CO. LLC holds $1,234,584,311 across 31 Biotechnology names. ELVN ranks #20 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
281,500 | $151,151,425 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
789,241 | $147,809,054 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
3,431,030 | $132,780,861 | |
| 4 | ARGX |
Argenx SE
|
108,253 | $100,433,885 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
166,581 | $82,745,780 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
540,977 | $63,332,177 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
398,994 | $48,908,684 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
590,074 | $48,132,336 |
All Filings in ELVN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,786,019 | 330,759 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $3,882,450 | 197,279 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $8,689,747 | 386,211 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,199,744 | 321,055 | Shares | Other | 2024-12-13 | |
| No filing history on record for this holder in this stock. | ||||||